The diluted disinfectants crisis in Romania of 2016 characterized a critical time in the evolution of the national health system, arose as a result of researching nonconformities in relation to legal rules, parameters of products disinfectants purchased and used in medical institutions in Romania.
In the spring of 2016, the press revealed that the Romanian health system was widely using diluted disinfectants bought from Hexi Pharma, which had been involved in a similar scandal back in 2006.
[3] Thor, another product made by Hexi Pharma, had been tested in France in laboratories of a competitor, ANIOS, which found a different recipe to the one indicated.
[5] On 6 May 2016, around five hundred people protested in Bucharest, amid a severe sub financing of the health system in a country where thousands of Romanian specialists emigrate annually, and bribery and informal payments are practices endemic in hospitals nationwide.
Prime Minister Dacian Cioloș assumed the interim [7] until the appointment of his successor, Vlad Voiculescu, on 20 May 2016.